Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: Cases from Mansoura, Egypt

Hematology

Volumn 11, Issue 5-6, 2006, Pages 341-349

  Settin, A ^a   Al Haggar, M ^a   Al Dosoky, T ^a   Al Baz, R ^a   Abdelrazik, N ^a   Fouda, M ^b   Aref, S ^b   Al Tonbary, Y ^a  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYTARABINE; DOXORUBICIN; HEMOGLOBIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD CELL COUNT; BONE MARROW EXAMINATION; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 10P; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 12Q; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 21; CHROMOSOME 22; CHROMOSOME 2P; CHROMOSOME 3Q; CHROMOSOME 5; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; CYTOGENETICS; DEATH; DIPLOIDY; DRUG TREATMENT FAILURE; EGYPT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOPHENOTYPING; INFANT; KARYOTYPE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MONOSOMY X; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT;

ADOLESCENT; BIOLOGICAL MARKERS; BONE MARROW EXAMINATION; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DRUG RESISTANCE, NEOPLASM; EGYPT; FEMALE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PROGNOSIS; REMISSION INDUCTION;

EID: 34250741906     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600938174     Document Type: Article

References (66)

1. Friedmann, AM and Weinstein, HJ (2000) The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist, 5, pp. 321-328.
2. Hashino, S. and Imamura, M. (1997) Clinical application gene technology for diagnosis and treatment of leukemia. Rinsho Byori, 45:1, pp. 58-65.
3. Heim, S. and Smeland, EB (1998) Molecular genetic diagnosis of leukemia and lymphoma. Tidsskr Nor Laegeforen, 118:16, pp. 2511-2518.
4. Donadieu, J. and Hill, C. (2001) Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: A methodological review. Br J Haematol, 115:1, pp. 34-45.
5. Avet-Loiseau, H. (1999) FISH analysis at diagnosis in acute lymphoblastic leukemia. Leuk Lymphoma, 33, p. 441.
6. Joyce, CA, Ross, FM and Dennis, NR (1999) Multipaint FISH: A rapid and reliable way to define cryptic and complex abnormalities. Clin Genet, 56, pp. 192-199.
7. Lanzowsky, P. (2000) Leukemia: Manual of pediatric haematology and oncology, pp. 359-409.
8. (1999) SPSS: Statistical package for social science, SPSS Inc., Chicago, IL
9. Luken, J. (1993) Acute lymphocytic leukemia. Wintrobe's clinical haematology, pp. 1892-1919. Lea and Febiger, Philadelphia, London
10. Steinherz, PG, Gaynon, PS and Breneman, JC (1996) Cytoreduction and prognosis in acute lymphoblastic leukemia; the importance of early marrow response: Report from the children's cancer group. J Clin Oncol, 14, pp. 389-398.
11. Nachman, J., Sather, HN and Gaynon, PS (1997) Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: A report from the children's cancer group. J Clin Oncol, 15, pp. 2222-2230.
12. Smith, M., Arthur, D. and Camitta, B. (1996) Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin oncol, 14:1, pp. 18-24.
13. Sather, HN, Miller, D. and Nesbit, M. (1981) Difference in prognosis for boys and girls with acute lymphoblastic leukemia. Lancet, 1, p. 739.
14. Chessells, JM, Richards, SM and Bailey, CC (1995) Gender and treatment outcome in childhood lymphoblastic leukemia: Report from the MRC UKALL trials. Br J Haematol, 89:2, pp. 364-372.
15. Hemminki, K. (2001) A population-based study of familial soft tissue tumors. J Clin Epidemiol, 54:4, pp. 411-416.
16. Hammond, D., Sather, H. and Nesbit, M. (1986) Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol, 14, pp. 124-134.
17. Eguiguren, JM, Schell, MJ and Crist, WM (1992) Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood, 79, p. 871.
18. Miller, DR (1980) Acute lymphoblastic leukemia. Pediatr Clin North Am, 27, pp. 269-275.
19. Ibrahim, WN, Sabry, FH and Saleh, AI (1988) Surface markers analysis and correlation with FAB classification in Egyptian infants and children with acute lymphoblastic leukemia (ALL). Egypt J Haematol, 13:1, pp. 19-25.
20. Baehner, RL and Miller, DR (1984) Haematologic malignancies: Leukemia and lymphoma. Blood diseases of infancy and childhood, pp. 619-721. CV Mosby Company, Missouri
21. Khalifa, AS, Mokhtar, GM and Gaballah, M. (1988) Clinico-epidemiological study of acute childhood leukemia in Egypt. Egypt J Haematol, 13:3, pp. 167-188.
22. Khalifa, AS, Mokhtar, GM and Ai, Of (1982) Behaviour of acute childhood leukemia in Egypt. Egypt J oncol, 2, p. 27.
23. Miller, DR, Kraile, M. and Blever, WA (1985) Prognostic implications of blast cells morphology in childhood acute lymphoblastic leukemia. A report from the children's cancer study group. Cancer Treat Rep, 69, pp. 1211-1281.
24. Van Eys, J., Pullen, J. and Head, D. (1986) The French American British (FAB) classification of leukemia. The paediatric oncology group experience with lymphocytic leukemia. Cancer, 57, pp. 1046-1052.
25. Miller, DR, Leikin, S., Albo, V., Sather, H. and Hammond, D. (1981) Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL). Br J Haematol, 48:2, pp. 199-206.
26. Lilleyman, JS, Hann, IM, Stevens, RF, Eden, OB and Richards, SM (1986) French American British (FAB) morphological classification of childhood lymphoblastic leukemia and its clinical importance. J Clin Pathol, 39:9, pp. 998-1002.
27. Pui, CH, Raimondi, SC and Crist, WM (1992) Chromosomal abnormalities in childhood acute lymphoblastic leukemia. Recent advances in hematology, pp. 89-105.
28. Secker-Walker, LM, Lawler, SD and Hardisty, RM (1978) Prognostic implications of chromosomal findings in acute lymphoblastic leukemia at diagnosis. Br Med J, 2:6151, pp. 1529-1530.
29. Pui, CH, Grist, WM and Look, AT (1990) Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood, 76, pp. 1449-1463.
30. Kaneko, Y., Rowley, JD and Veriajojis, D. (1982) Correlation of karyotype with clinical features in acute lymphoblastic leukemia. Cancer Res, 42, p. 2918.
31. Fletcher, JA, Kimball, VM and Lynch, E. (1989) Prognosis implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia. Blood, 74, p. 2130.
32. Kobayashi, H., Maseki, N. and Homma, C. (1994) Clinical significance of chromosome abnormalities in childhood acute lymphoblastic leukemia in Japan. Leukemia, 8:11, pp. 1930-1944.
33. Hafez, M., Mansour, AK and Mahmoud, LA (1999) Clinical significance of chromosome abnormalities in children with acute lymphoblastic leukemia. Egypt J Haematol, p. 24.
34. Rowley, JD, Reshmi, S. and Carlson, K. (1999) Spectral karyotype analysis of T-cell acute leukemia. Blood, 93, p. 2038.
35. Viehmann, S., Borkhardt, A. and Lampert, F. (1999) Multiplex PCR a rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia. Ann Hematol, 78, p. 157.
36. Bloomfield, CD, Lindquist, LL and Arthur, D. (1981) Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Res, 41, p. 4838.
37. Secker-Walker, LM, Swansbury, GJ and Lawler, SD (1982) Cytogenetics of acute lymphobalstic leukemia in children as a factor in prediction of long-term survival. Br J Hematol, 52, p. 389.
38. Micallef-Eynaud, PD, Eden, OB and Grace, E. (1993) Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol, 10, p. 25.
39. Heerma, NA, Nachman, JB and Sather, HN (1999) Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: A report from the children's cancer group. Blood, 94:12, pp. 4036-4045.
40. Bloomfield, CD, Secker-Walker, LM and Goldman, AI (1989) Six year follow up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet, 40, pp. 171-189.
41. Secker-Walker, LM and Goldman, JM (1989) Cytogenetics and leukemogenesis. Postgraduate hematology, p. 359. Heineman Professional Publishing Ltd, London
42. Ito, C., Kumagai, M. and Manabe, A. (1999) Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis. Blood, 93:1, pp. 315-320.
43. Mehdipour, P., Mirfakhraie, R., Jahani, M. and Mehdipour, AR (2003) Karyotypic evolution: Cytogenetics follow-up study in childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev, 4:4, pp. 358-368.
44. Nordgren, A., Nordenskjld, M. and Donald, A Mac (1997) A case of acute lymphoblastic leukemia, near-triploidy, and poor outcome. Cancer Genet Cytogenet, 99:2, pp. 93-96.
45. Zemanova, Z., Michalova, K. and Sindelarova, L. (2005) Prognostic value of structural chromosomal rearrangements and small cell clones with high hyperdiploidy in children with acute lymphoblastic leukemia. Leuk Res, 29:3, pp. 273-281.
46. Stark, B., Jeison, M. and Gobuzov, R. (2001) Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid line: Detection by fluorescence in situ hybridization. Cancer Genet Cytogenet, 128:2, pp. 108-113.
47. Harrison, CJ, Moorman, AV and Broadfield, ZJ (2004) Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia. Br J Hematol, 125:5, pp. 552-559.
48. Harris, MB, Shuster, JJ and Andrew, SA (1992) Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure. A pediatric oncology group study. Blood, 79, pp. 3316-3324.
49. Watson, MS, Carrell, AJ and Shuster, JJ (1993) Trisomy 21 in childhood acute lymphoblastic leukemia. A pediatric oncology group study. Blood, 82, pp. 3098-3102.
50. Berger, R. (1997) Acute lymphoblastic leukemia and chromosome 21. Cancer Genet Cytogenet, 94:1, pp. 8-12.
51. Williams, DL, Harber, J. and Murphy, SB (1986) Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood, 68, p. 205.
52. Williams, DL, Harris, A. and Williams, KG (1984) A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet, 13, p. 239.
53. Morrison-Delap, S. and Uw (2000) Waisman center cytogenetics laboratory. Cancer cytogenetics
54. Hafez, M., El-Tahan, H. and El-Morsi, Z. (1985) Genetic environmental interaction in acute lymphatic leukemia. Familial cancer, pp. 161-166.
55. Pui, CH (1995) Childhood leukemias. N Engl J Med, 332, p. 1618.
56. Melo, JV (1996) The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood, 88, p. 2375.
57. Bartolo, C. and Viswanatha, DS (2000) Molecular diagnosis in pediatric acute leukemia. Clin North Am, 20, pp. 139-156.
58. Ariffin, H., Chen, SP, Wong, HL and Yeoh, A. (2003) Validation of a multiplex RT-PCR assay for screening significant oncogene fusion transcripts in children with acute lymphoblastic leukaemia. Singapore Med J, 44:10, pp. 517-520.
59. Kantarjian, HM, Diesseroth, A. and Kurzrock, M. (1993) Chronic myelogenous leukemia: A concise up-date. Blood, 82, p. 691.
60. Foroni, L., Harrison, CJ and Hoffbrand, AV (1999) Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukemia by molecular analysis. Br J Haematol, 105:1, pp. 7-24.
61. Baker, SJ, Fearon, ER and Wilson, JKV (1990) Suppression of human colorectal carcinoma cell growth by wild-type P53. Science, 249, p. 912.
62. Wada, M., Bartram, C. and Nakamura, H. (1993) Analysis of P53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood, 82, p. 3163.
63. Maroni, G. (2001) Cancer: A genetic disease in molecular and genetic analysis of human traits, pp. 229-230.
64. Crist, WM, Carroll, AJ and Shuster, JJ (1990) Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): A pediatric oncology group study. Blood, 76, pp. 117-122.
65. Chen, CS, Sorensen, PH and Domer, PH (1993) Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood, 81, pp. 2386-2393.
66. Behm, FG, Raimondi, SC and Frestedt, JL (1996) Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood, 87, pp. 2870-2877.